Senior insider sale
Chief Financial Officer at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$12.0K
1.30K shares
What this filing means
GOLDAN KEITH A. plans to sell 1.30K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $12.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/16/2025ACC: 0001959173-25-004606
Officer· Chief Financial Officer
Since Jun 2022
1.30K
Shares to sell
$12.0K
Approx. market value
1.30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/30/2025
1.30KTotal acquired1.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/30/2025 | Restricted Stock Vesting Compensation | 1.30K | — |
| Total | 1.30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.30K
Market value
$12.0K
7/16/2025
Total
Units
1.30K
Value
$12.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/16/2025 | 1.30K | $12.0K | NASDAQ | Planned |
| Total | 1.30K | $12.0K | ||